Naturex posts 12.3% sales growth

The company's current operating income also grew by 10.4%

Plant based ingredients specialist Naturex recorded a 12.3% increase in group sales for the 2011 financial year accompanied by a 10.4% increase in current operating income. Growth was attributed to the combined effects of a reinforced structure, an enriched range of products and commercial synergies that benefited the company’s three markets (personal care, food & beverage and nutrition & health) and the geographical regions in which it operates, with an acceleration in growth in the emerging countries.

A capital increase launched on 4 October 2011 enabled the company to raise €48.8m to contribute to the financing of a new external growth cycle. With its acquisition in late October of French botanical extracts manufacturer and supplier Burgundy and the impact of exchange rates over the period, group revenue for 2011 grew 12% to €253.6m.

After taking the costs of acquisition fees, restructuring costs and the revaluation of benefits paid to Swiss personnel into account, the company’s operating income for 2011 stood at €28.5m, up 4.6% on the previous year, with an operating margin of 11.3% of revenue.

"Once again, these excellent results confirm the quality of Naturex's positioning in mature markets which have recorded solid performance despite the difficult economic context, as well as in very dynamic emerging markets which are increasingly contributing to our growth," said Jacques Dikansky, president, ceo and founder of Naturex.

"In an economic situation which is starting to improve, we are moving through 2012 with confidence, and our main priorities are on the one hand to quickly incorporate our latest acquisitions in order to create synergies within the Group, and on the other hand, to finalise our acquisition programme in order to generate additional growth, sustainable and profitable."